Panzyma Laboratories S.A., established in 1959 in Nicaragua, is a leading pharmaceutical company dedicated to the development of innovative and high-quality healthcare products. Under the leadership of its founder, Sr. Eigil Hoigjelle, Panzyma has successfully operated in the field of human medicine, focusing on enhancing the quality of life for families while contributing to job creation.

Committed to excellence, Panzyma Laboratories offers a diverse portfolio of over 200 active ingredients, designed with ethical considerations and appealing presentations. The company produces various pharmaceutical forms, ensuring that it meets the healthcare needs of its community. In addition, Panzyma updates its Vademecum annually, providing healthcare professionals with current and comprehensive information about its offerings.

With a vision to be the leading laboratory in Nicaragua's pharmaceutical industry, Panzyma Laboratories aims to strengthen its market presence and foster robust relationships with commercial partners, positioning its brand as a symbol of quality and innovation in healthcare.